Hypereosinophilic syndromes. Established and new treatment options

BioDrugs

Volumn 7, Issue 5, 1997, Pages 341-355

  Butterfield, Joseph H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTICOAGULANT AGENT; CORTICOSTEROID; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; HYDROXYUREA; INTERLEUKIN 5; METHYLPREDNISOLONE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ADDISON DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; ASTHMA; BRONCHOPULMONARY ASPERGILLOMA; CANCER; CARDIOVASCULAR DISEASE; CELL COUNT; CHURG STRAUSS SYNDROME; EOSINOPHILIA; EOSINOPHILIA MYALGIA SYNDROME; EOSINOPHILIC FASCIITIS; EOSINOPHILIC GASTROENTERITIS; HUMAN; HYPEREOSINOPHILIC SYNDROME; INFECTION; LEUKAPHERESIS; LEUKEMIA; LOEFFLER PNEUMONIA; LUNG DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; PUVA; REVIEW; SKIN DISEASE; THROMBOSIS;

EID: 0030756057     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199707050-00002     Document Type: Review

References (164)

1. Hardy WR, Anderson RE. The hypereosinophilic syndromes. Ann Intern Med 1968 Jun; 68 (6): 1220-9
2. Chusid MJ, Dale DC, West BC, et al. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975 Jan; 54 (1): 1-27
3. Dale DC, Hubert RT, Fauci A. Eosinophil kinetics in the hypereosinophilic syndrome. J Lab Clin Med 1976 Mar; 87 (3): 487-95
4. Fauci AS, Harley JB, Roberts WC, et al. NIH conference: the idiopathic hypereosinophilic syndrome: clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982 Jul; 97 (1): 78-92
5. da Silva MA, Heerema N, Schwenk Jr GR, et al. Evidence for the clonal nature of hypereosinophilic syndrome. Cancer Genet Cytogenet 1988 May; 32 (1): 109-15
6. Luppi M, Marasca R, Morselli M, et al. Clonal nature of hypereosinophilic syndrome [letter]. Blood 1994 Jul 1; 84 (1): 349-50
7. Malbrain ML, Van den Bergh H, Zachee P. Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: complete haematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality. Br J Haematol 1996 Jan; 92 (1): 176-83
8. Uhrbrand H. The number of circulation eosinophils: normal figures and spontaneous variations. Acta Med Scand 1958; 160: 99-104
9. Booth BH. Diagnosis of immediate hypersensitivity. In. Patterson R, Zeiss CR, Grammer LC, et al. editors. Allergic diseases: diagnosis and management. 4th ed. Philadelphia: JB Lippincott Company, 1993: 216
10. Rosenberg M, Patterson R, Mintzer R, et al. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977 Apr; 86 (4): 405-14
11. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1984 Nov; 74 (5): 645-53
12. Crofton J, Douglas A. Respiratory diseases. 2nd ed. Oxford: Blackwell Scientific Publications, 1975: 444
13. Spry C. Eosinophilia in Addison's disease. Yale J Biol Med 1976 Sep; 49(4): 411-3
14. Weller PF. Eosinophilia. In: Rich RR, Fleisher TA, Schwartz BD, et al., editors. Clinical immunology: principles and practice. Vol 1, St. Louis: Mosby-Year Book, 1996: 1022-31
15. Kan H, Ogata T, Taniyama A, et al. Extraordinarily high eosinophilia and elevated serum interleukin-5 level observed in a patient infected with Paragonimus westermani. Pediatrics 1995 Aug; 96 (2): 351-4
16. Kueck BD, Smith RE, Parkin J, et al. Eosinophilic leukemia: a myeloproliferative disorder distinct from the hypereosinophilic syndrome. Hematol Pathol 1991; 5 (4): 195-205
17. Lonnqvist B, Gahrton G, Eriksson P, et al. Isochromosome 17 in a patient with a myeloproliferative disorder terminating in eosinophilic leukemia. Acta Med Scand 1979; 206 (4): 321-5
18. Chusid MJ, Dale DC. Eosinophilic leukemia: remission with vincristine and hydroxyurea. Am J Med 1975 Aug; 59 (2): 297-300
19. Yates P, Potter MN. Eosinophilic leukaemia with an abnormality of 5q31, the site of the IL-5 gene. Clin Lab Haematol 1991; 13 (2): 211-5
20. Chan LC, Kwong YL, Lie AK, et al. A case of Philadelphia-negative, M-BCR rearranged eosinophilic leukaemia with trisomy 8 localized by in situ hybridization. Leukemia 1994 Jan; 8 (1): 195-8
21. Singh RP, Emmatty JG, Bhama T. Hodgkin's lymphoma presenting as hypereosinophilia syndrome. J Assoc Physicians India 1984 Jun; 32 (6): 528-9
22. Manthorpe R, Egeberg J, Hesselvik M, et al. Unique eosinophil granules in a case of T-cell lymphoma. Scand J Haematol 1977 Aug; 19 (2): 129-44
23. Kimura H, Abe R, Shiga Y, et al. A case of acute myelogenous leukaemia associated with eosinophilia: cytogenetic study of eosinophilic colonies showing the origin of the normal clone. Acta Haematol 1987; 77 (1): 15-9
24. Spitzer G, Garson OM. Lymphoblastic leukemia with marked eosinophilia: a report of two cases. Blood 1973 Sep; 42 (3): 377-84
25. Koeffler HP, Levine AM, Sparkes M, et al. Chronic myelocytic leukemia: eosinophils involved in the malignant clone. Blood 1980 Jun; 55 (6): 1063-5
26. Miranda RN, Esparza AR, Sambandam S, et al. Systemic mast cell disease presenting with peripheral blood eosinophilia. Hum Pathol 1994 Jul; 25 (7): 727-30
27. Isaacson NH, Rapoport P. Eosinophilia in malignant tumors: its significance. Ann Intern Med 1946 Dec; 25 (6): 893-902
28. Viola MV, Chung E, Mukhopadhyay MG. Eosinophilia and metastatic carcinoma. Med Ann Dist Columbia 1972 Jan; 41 (1): 1-3
29. Lieske TR, Sunderrajan EV, Passamonte PM. Bronchoalveolar lavage and technetium-99m glucoheptonate imaging in chronic eosinophilic pneumonia. Chest 1984 Feb; 85 (2): 282-4
30. McEvoy JD, Donald KJ, Edwards RL. Immunoglobulin levels and electron microscopy in eosinophilic pneumonia. Am J Med 1978 Mar; 64 (3): 529-36
31. Allen JN, Pacht ER, Gadek JE, et al. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989 Aug 31; 321 (9): 569-74
32. Umeki S. Reevaluation of eosinophilic pneumonia and its diagnostic criteria. Arch Intern Med 1992 Sep; 152 (9): 1913-9
33. Neva FA, Ottesen EA. Tropical (filarial) eosinophilia. N Engl J Med 1978 May 18; 298 (20): 1129-31
34. Farnam J, Alperin JB, Ladoulis C, et al. Mononeuritis multiplex and eosinophilia in a patient with asthma. Ann Allergy 1985 Jul; 55 (1): 14-5, 33-5
35. Rose GA. The natural history of polyarteritis. BMJ 1957 Nov 16; 2: 1148-52
36. Lanham JG, Elkon KB, Pusey CD, et al. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984 Mar; 63 (2): 65-81
37. Chen KR, Su WP, Pittelkow MR, et al. Eosinophilic vasculitis in connective tissue disease. J Am Acad Dermatol 1996 Aug; 35 (2): 173-82
38. Nutman TB, Ottesen EA, Cohen SG. Eosinophilia and eosinophil-related disorders. In: Middleton Jr E, Reed CE, Ellis EF, et al., editors. Allergy: principles and practice. 3rd ed. Vol 2. St. Louis: CV Mosby Company, 1988: 868
39. Nakanishi K, Kaneko T, Yano F, et al. Marked eosinophilia induced by nafamostat mesilate, an anticoagulant in a hemodialysis patient. Nephron 1992; 62 (1): 97-9
40. van Haelst Pisani C, Kovach JS, Kita H, et al. Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer. Blood 1991 Sep 15; 78 (6): 1538-44
41. Freundlich B, Worth VP, Rook AH, et al. L-tryptophan ingestion associated with eosinophilic fasciitis hut not progressive systemic sclerosis. Ann Intern Med 1990 May 15; 112 (10): 758-62
42. Cello JP. Eosinophilic gastroenteritis - a complex disease entity. Am J Med 1979 Dec; 67 (6): 1097-104
43. Johnstone JM, Morson BC. Eosinophilic gastroenteritis. Histopathology 1978 Sep; 2 (5): 335-48
44. Gleich GJ, Schroeter AL, Marcoux JP, et al. Episodic angioedema associated with eosinophilia. N Engl J Med 1984 Jun 21; 310 (25): 1621-6
45. Bushkell LL, Jordon RE. Bullous pemphigoid: a cause of peripheral blood eosinophilia. J Am Acad Dermatol 1983 May; 8 (5): 648-51
46. Chang YT, Liu HN, Wong CK. Bullous pemphigoid - a report of 86 cases from Taiwan. Clin Exp Dermatol 1996 Jan; 21 (1): 20-2
47. Kuo TT, Shih LY, Chan HL. Kimura's disease. Involvement of regional lymph nodes and distinction from angiolymphoid hyperplasia with eosinophilia. Am J Surg Pathol 1988 Nov; 12 (11): 843-54
48. Fisher GB, Greer KE, Cooper PH. Eosinophilic cellulitis (Wells' syndrome). Int J Dermatol 1985 Mar; 24 (2): 101-7
49. Peters MS, Schroeter AL, Gleich GJ. Immunofluorescence identification of eosinophil granule major basic protein in the flame figures of Wells' syndrome. Br J Dermatol 1983 Aug; 109 (2): 141-8
50. Martin RW, Duffy J, Engel AG, et al. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion: clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med 1990 Jul 15; 113 (2): 124-34
51. Kaufman LD, Finn Jr AF, Seidman RJ, et al. Fosinophilic neuritis, perimyositis, and vasculitis associated with ingestion of L-tryptophan. J Rheumatol 1990 Jun; 17 (6): 795-800
52. Clauw DJ, Crofford LJ. Eosinophilic rheumatic disorders. Rheum Dis Clin North Am 1995 Feb; 21 (1): 231-46
53. Michet Jr CJ, Doyle JA, Ginsburg WW. Eosinophilic fasciitis: report of 15 cases. Mayo Clin Proc 1981 Jan; 56 (1): 27-34
54. Parrillo JE, Fauci AS, Wolff SM. The hypereosinophilic syndrome: dramatic response to therapeutic intervention. Trans Asoc Am Physicians 1977; 90: 135-44
55. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994 May 15; 83 (10): 2759-79
56. Schooley RT, Parrillo JE, Wolff SM, et al. Management of the idiopathic hypereosinophilic syndrome. In: Mahmoud AAF, Austen KF, Stolper SA, editors. Eosinophils in health and disease. New York: Grune & Stratton, 1980: 323-43
57. Confalonieri M, Tacconi F, De Amici M, et al. Benign idiopathic hypereosinophilia: a feeble masquerader or a smouldering form of the hypereosinophilic syndrome? Haematologica 1995 Jan-Feb; 80 (1): 50-3
58. Harley JB, Fauci AS, Gralnick HR. Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome. Am J Cardiol 1983 Aug; 52 (3): 321-4
59. Spry CJ, Davies J, Tai PC, et al. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 1983 Winter; 52 (205): 1-22
60. Cogan E, Schandene L, Crusiaux A, et al. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994 Feb 24; 330 (8): 535-8
61. Takai K, Sanada M. Hypereosinophilic syndrome evolving to acute lymphoblastic leukemia. Int J Hematol 1991 Jun; 54 (3): 231-9
62. Needleman SW, Mane SM, Gutheil JC, et al. Hypereosinophilic syndrome with evolution to myeloproliferative disorder: temporal relationship to loss of Y chromosome and c-N-ras activation. Hematol Pathol 1990; 4 (3): 149-55
63. Kim CJ, Park SH, Chi JG. Idiopathic hypereosinophilic syndrome terminating as disseminated T-cell lymphoma. Cancer 1991 Feb 15; 67 (4): 1064-9
64. Higuchi W, Koike T, Ihizumi T, et al. Hypereosinophilic syndrome terminating in acute myelogenous leukemia. Acta Haematol 1993; 90 (3): 165-6
65. Dourov N, Cauchie C, de Maertelaere-Laurent E, et al. Myelome et hypereosinophilie: reaction leucemoide a eosinophiles associée à un myelome. Nouv Rev Fr Hematol 1981; 23 (4): 227-34
66. Ishida T, Morita M, Kawanami M, et al. A case of hypereosinophilic syndrome associated with eosinophilic endocarditis. Kokyu To Junkan 1989 Aug; 37 (8): 909-13
67. Bush RK, Geller M, Busse WW, et al. Response to corticosteroids in the hypereosinophilic syndrome: association with increased serum IgE levels. Arch Intern Med 1978 Aug; 138 (8): 1244-6
68. Parrillo JE, Fauci AS, Wolff SM. Therapy of the hypereosinophilic syndrome. Ann Intern Med 1978 Aug; 89 (2): 167-72
69. Rizzari C, Conter V, D'Angelo P, et al. Efficacy of prolonged low-dose steroid treatment in a child with idiopathic hypereosinophilic syndrome: a case report [letter]. Pediatr Hematol Oncol 1995 Mar-Apr; 12 (2): 209-12
70. Edwards D, Wald JA, Dobozin BS, et al. Troleandomycin and methylprednisolone for treatment of the hypereosinophilic syndrome [letter]. N Engl J Med 1987 Aug 27; 317 (9): 573-4
71. Wallen N, Kita H, Weiler D, et al. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 1991 Nov 15; 147 (10): 3490-5
72. Lamas AM, Leon OG, Schleimer RP. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J Immunol 1991 Jul 1: 147 (1): 254-9
73. Cox G, Ohtoshi T, Vancheri C, et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 1991 Jun; 4 (6): 525-31
74. Her E, Frazer J, Austen KF, et al. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils: cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest 1991 Dec; 88 (6): 1982-7
75. Hallsworth MP, Litchfield TM, Lee TH. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils. Immunology 1992 Feb; 75 (2): 382-5
76. Schrezenmeier H, Thome SD, Tewald F, et al. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome. Exp Hematol 1993 Feb; 21 (2): 358-65
77. Fang J, Viksman MY, Ebisawa M, et al. Increased circulating levels of interleukin-5 in a case of steroid-resistant hypereosinophilic syndrome with ileal involvement. J Allergy Clin Immunol 1994 Jul; 94 (1): 129-31
78. Butterfield JH, Leiferman KM, Abrams J, et al. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 1992 Feb 1; 79 (3): 688-92
79. Fruehauf S, Fiehn C, Haas R, et al. Sustained remission of idiopathic hypereosinophilic syndrome following alpha-interferon therapy. Acta Haematol 1993; 89 (2): 91-3
80. Butterfield JH, Ackerman SJ, Weiler D, et al. Effects of glucocorticoids on eosinophil colony growth. J Allergy Clin Immunol 1986 Sep; 78 (3 Pt 1): 450-7
81. Bjornson BH, Harvey JM, Rose L. Differential effect of hydrocortisone on eosinophil and neutrophil proliferation. J Clin Invest 1985 Sep; 76 (3): 924-9
82. Journey LJ, Burdman J, George P. Ultrastructural studies on tissue culture cells treated with vincristine (NSC-67574). Cancer Chemother Rep 1968 Jun; 52 (4): 509-17
83. Van Slyck EJ, Adamson TC III. Acute hypereosinophilic syndrome: successful treatment with vincristine, cytarabine, and prednisone. JAMA 1979 Jul 13; 242 (2): 175-6
84. Sakamoto K, Erdreich-Epstein A, deClerck Y, et al. Prolonged clinical response to vincristine treatment in two patients with idiopathic hypereosinophilic syndrome. Am J Pediatr Hematol Oncol 1992 Nov; 14 (4): 348-51
85. Marshall GM, White L. Effective therapy for a severe case of the idiopathic hypereosinophilic syndrome. Am J Pediatr Hematol Oncol 1989 Summer; 11 (2): 178-83
86. Wynn SR, Sachs MI, Keating MU, et al. Idiopathic hypereosinophilic syndrome in a 5 1/2-month-old infant. J Pediatr 1987 Jul; 111 (1): 94-7
87. Cofrancesco E, Cortellaro M, Pogliani E, et al. Response to vincristine treatment in a case of idiopathic hypereosinophilic syndrome with multiple clinical manifestations. Acta Haematol 1984; 72 (1): 21-5
88. Clarkson BD, Dowling MD, Gee TS, et al. Treatment of acute leukemia in adults. Cancer 1975 Aug; 36 (2): 775-95
89. Eakin DL, Gill DP, Weiss GB. Response of hypereosinophilic syndrome to 6-thioguanine and cytarabine. Cancer Treat Rep 1982 Mar; 66 (3): 545-7
90. Smit AJ, van Essen LH, de Vries EG. Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide. Cancer 1991 Jun 1; 67 (11): 2826-7
91. Bourrat E, Lebbe C, Calvo F. Etoposide for treating the hypereosinophilic syndrome [letter]. Ann Intern Med 1994 Dec 1; 121 (11): 899-900
92. Raghavachar A, Fleischer S, Frickhofen N, et al. T lymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome. J Immunol 1987 Dec 1; 139 (11): 3753-8
93. Shupack JL, Kenny C, Jondreau L, et al. Decreased peripheral blood eosinophil counts in severe psoriatic patients treated with low-dose cyclosporine A. Dermatology 1992; 185 (3): 202-4
94. Zabel P, Schlaak M. Cyclosporin for hypereosinophilic syndrome. Ann Hematol 1991 Jun; 62 (6): 230-1
95. Broxmeyer HE, Lu L, Platzer E, et al. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol 1983 Sep; 131 (3): 1300-5
96. Valerius T, Repp R, Kalden JR, et al. Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action. J Immunol 1990 Nov 1; 145 (9): 2950-8
97. Schandene L, Del Prete GF, Cogan E, et al. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J Clin Invest 1996 Jan 15; 97 (2): 309-15
98. Murphy PT, Fennelly DF, Stuart M, et al. Alfa-interferon in a case of hypereosinophilic syndrome. Br J Haematol 1990 Aug; 75 (4): 619-20
99. Zielinski RM, Lawrence WD. Interteron-alpha for the hypereosinophilic syndrome. Ann Intern Med 1990 Nov 1; 113 (9): 716-8
100. Busch FW, Schmidt H, Steinke B. Alpha-interferon for the hypereosinophilic syndrome [letter]. Ann Intern Med 1991 Feb 15; 114 (4): 338-9
101. Bockenstedt PL, Santinga JT, Bolling SF. Alpha-interferon treatment for idiopathic hypereosinophilic syndrome. Am J Hematol 1994 Mar; 45 (3): 248-51
102. Canonica GW, Passalacqua G, Pronzato C, et al. Effective long-term alpha-interferon treatment for hypereosinophilic syndrome. J Allergy Clin Immunol 1995 Jul; 96 (1): 131-3
103. Coutant G, Bletry O, Prin L, et al. Traitement des syndromes hypereosinophiliques à expression myeloproliferative par l'association hydroxyuree-interferon alpha: à propos de 7 observations. Ann Med Interne Paris 1993; 144 (4): 243-50
104. Butterfield JH, Gleich GJ. Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med 1994 Nov 1; 121 (9): 648-53
105. Kobayashi M, Katayama T, Ochiai S, et al. Interferon-alpha therapy in the myeloproliferative variants of hypereosinophilic syndrome. Rinsho Ketsueki 1993 Mar; 34 (3): 367-72
106. Schandene L, Fersler A, Mascart-Lemone F, et al. T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol 1993 Jan: 23 (1): 56-60
107. Hanifin JM, Schneider LC, Leung DY, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993 Feb; 28 (2 Pt 1): 189-97
108. Prin L, Plumas J, Gruart V, et al. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome. Blood 1991 Nov 15; 78 (10): 2626-32
109. Kantarjian HM, Smith TL, O'Brien S, et al. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. Ann Intern Med 1995 Feb 15; 122 (4): 254-61
110. Quiquandon I, Claisse JF, Capiod JC, et al. Alpha-interferon and hypereosinophilic syndrome with trisomy 8: karyotypic remission [letter]. Blood 1995 Apr 15; 85 (8): 2284-5
111. van den Anker-Lugtenburg PJ, van't Veer MH. Alpha-interferon in a case of hypereosinophilic syndrome [letter]. Br J Haematol 1991 Feb; 77 (2): 258
112. Blanquer A, Lopez A, Tarin F, et al. Alpha interferon for hypereosinophilic syndrome [letter]. Am J Hematol 1994 Dec; 47 (4): 332-3
113. Sato H, Danbara M, Tamura M, et al. Eosinophilic leukaemia with a t(2; 5) (p23; q35) translocation. Br J Haematol 1994 Jun; 87 (2): 404-6
114. Hendrick A. Psychosis during interferon in eosinophilic leukaemia. Clin Lab Haematol 1994 Sep; 16 (3): 245-6
115. Hansen PB, Johnsen HE, Hippe E. Hypereosinophilic syndrome treated with alpha-interferon and granulocyte colony-stimulating factor but complicated by nephrotoxicity. Am J Hematol 1943 May; 43 (1): 66-8
116. Chambers LA, Leonard SS, Whatmough AE, et al. Management of hypereosinophilic syndrome with chronic plasma- and leukapheresis. Prog Clin Biol Res 1990; 337: 83-5
117. Pineda AA, Brzica Jr SM, Taswell HF. Continuous- and semicontinuous-flow blood centrifugation systems: therapeutic applications, with plasma-, platelet, lympha-, and eosinapheresis. Transfusion 1977 Sep-Oct; 17 (5): 407-16
118. Ellman L, Miller L, Rappeport J. Leukopheresis therapy of a hypereosinophilic disorder. JAMA 1974 Nov 18; 230 (7): 1004-5
119. Archimbaud E, Guyotat D, Guillaume C, et al. Hypereosinophilic syndrome with multiple organ dysfunction treated by allogeneic bone marrow transplantation. Am J Hematol 1988 Apr; 27 (4): 302-3
120. Fukushima T, Kuriyama K, Ito H, et al. Successful bone marrow transplantation for idiopathic hypereosinophilic syndrome. Br J Haematol 1995 May; 90 (1): 213-5
121. Sigmund DA, Flessa HC. Hypereosinophilic syndrome: successful allogeneic bone marrow transplanlation. Bone Marrow Transplant 1995 Apr; 15 (4): 647-8
122. Esteva-Lorenzo FJ, Meehan KR, Spitzer TR, et al. Allogeneic bone marrow transplantation in a patient with hypereosinophilic syndrome. Am J Hematol 1996 Feb; 51 (2): 164-5
123. Kazmierowski JA, Chusid MJ, Parrillo JE, et al. Dermatologic manifestations of the hypereosinophilic syndrome. Arch Dermatol 1978 Apr; 114 (4): 531-5
124. Wemmer U, Thiele B, Steigleder GK. Hypereosinophilic-Syndrom (HES) - erfolgreiche PUVA-Therapie. Hautarzt 1998 Jan; 39 (1): 42-4
125. van den Hoogenband HM, van den Berg WH, van Diggelen MW. PUVA therapy in the treatment of the skin lesions of the hypereosinophilic syndrome [letter]. Arch Dermatol 1985 Apr; 121 (4): 450
126. Newton JA, Singh AK, Greaves MW, et al. Aquagenic pruritus associated with the idiopathic hypereosinophilic syndrome Br J Dermatol 1990 Jan; 122 (1): 103-6
127. May LP, Kelly J, Sanchez M. Hypereosinophilic syndrome with unusual cutaneous manifestations in two men with HIV infection. J Am Acad Dermatol 1990 Aug; 23 (2 Pt 1): 202-4
128. Nir MA, Westfried M. Hypereosinophilic dermatitis: a distinct manifestation of the hypereosinophilic syndrome with response to dapsone. Dermatologica 1981; 162 (6): 444-50
129. Wood ML, Slater DN. Cutaneous manifestations of the hypereosinophilic syndrome treated with sodium cromoglycate. Clin Exp Dermatol 1984 Mar; 9 (2): 139-42
130. Leiferman KM, O'Duffy JD, Perry HO, et al. Recurrent incapacitating mucosal ulcerations: a prodrome of the hypereosinophilic syndrome. JAMA 1982 Feb 19; 247 (7): 1018-20
131. Akahoshi M, Hoshino S, Teramura M, et al. Recurrent oral and genital ulcers as the prodrome of the hypereosinophilic syndrome: report of a probable case. Nippon Naika Gakkai Zasshi 1987 Mar; 76 (3): 421-4
132. Butterfield JH, Gleich GJ, Gillham Jr RA, et al. Healing of recurrent incapacitating mucosal ulcers of the hypereosinophilic syndrome (HES) with interferon alfa 2B [abstract]. J Allergy Clin Immunol 1993; 91: 317
133. Gleich GJ, Loegering DA, Kueppers F, et al. Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules. J Exp Med 1974 Aug 1; 140 (2): 313-32
134. Hanowell ST, Kim YD, Rattan V, et al. Increased heparin requirement with hypereosinophilic syndrome. Anesthesiology 1981 Oct; 55 (4): 450-2
135. Slungaard A, Vercellotti GM, Tran T, et al. Eosinophil cationic granule proteins impair thrombomodulin function: a potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest 1993 Apr; 91 (4): 1721-30
136. Rohrbach MS, Wheatley CL, Slifman NR, et al. Activation of platelets by eosinophil granule proteins. J Exp Med 1990 Oct 1; 172 (4): 1271-4
137. Venge P, Dahl R, Hallgren R. Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res 1979; 14 (4-5): 641-9
138. Dahl R, Venge P. Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocyles. Thromb Res 1979; 14 (4-5): 599-608
139. Pincus SH, Ramesh KS, Wyler DJ. Eosinophils stimulate fibroblast DNA synthesis. Blood 1987 Aug; 70 (2); 572-4
140. Lombardi C, Rusconi C, Faggiano P, et al. Successful reduction of endomyocardial fibrosis in a patient with idiopathic hypereosinophilic syndrome: a case report. Angiology 1995 Apr; 46 (4): 345-51
141. Solley GO, Maldonado JE, Gleich GJ, et al. Endomyocardiopathy with eosinophilia. Mayo Clin Proc 1976 Nov; 51 (11): 697-708
142. Wolz DE, Granato JE, Giles HR, et al. A unique chromosomal abnormality in idiopathic hypereosinophilic syndrome presenting with cardiac involvement. Am Heart J 1993 Jul; 126 (1): 246-8
143. Parrillo JE, Borer JS, Henry WL, et al. The cardiovascular manifestations of the hypereosinophilic syndrome: prospective study of 26 patients, with review of the literature. Am J Med 1979 Oct; 67 (4): 572-82
144. Davies J, Spry CJ, Sapsford R, et al. Cardiovascular features of 11 patients with eosinophilic endomyocardial disease. Q J Med 1983 Winter, 52 (205): 23-39
145. Inoue K, Saida K, Yamashiro M, et al. Mitral valve replacement in idiopathic hypereosinophilic syndrome. Nippon Kyobu Geka Gakkai Zasshi 1991 Nov; 39 (11): 2068-73
146. Tanino M, Kitamura K, Ohta G, et al. Hypereosinophilic syndrome with extensive myocardial involvement and mitral valve thrombus instead of mural thrombi. Acta Pathol Jpn 1983 Nov; 33 (6): 1233-42
147. Tai PC, Ackerman SJ, Spry CJ, et al. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1987 Mar 21; 1 (8534): 643-7
148. Take M, Sekiguchi M, Hiroe M, et al. Clinical spectrum and endomyocardial biopsy findings in eosinophilic heart disease. Heart Vessels Suppl 1985; 1: 243-9
149. Fournial G, Schlanger R, Berthoumieu F, et al. Surgery for cardiac complications caused by endocardial mural fibrin deposits in a hypereosinophilic syndrome. Circulation 1982 May; 65 (5): 1010-4
150. Davies J, Sapsford R, Brooksby I, et al. Successful surgical treatment of two patients with eosinophilic endomyocardial disease. Br Heart J 1981 Oct; 46 (4): 438-45
151. Harley JB, McIntosh CL, Kirklin JJ, et al. Atrioventricular valve replacement in the idiopathic hypereosinophilic syndrome. Am J Med 1982 Jul; 73 (1): 77-81
152. Blake DP, Palmer TE, Olinger GN. Mitral valve replacement in idiopathic hypereosinophilic syndrome. J Thorac Cardiovasc Surg 1985 Apr; 89 (4): 630-2
153. Boustany Jr CW, Murphy GW, Hicks Jr GL. Mitral valve replacement in idiopathic hypereosinophilic syndrome. Ann Thorac Surg 1991 Jun; 51 (6): 1007-9
154. Smith MD, Metcalfe M, DeMaria AN, et al. Hypereosinophilic syndrome resulting in aortic and mitral stenosis: a case requiring double valve replacement. Am Heart J 1989 Feb; 117 (2): 475-9
155. Hendren WG, Jones EL, Smith MD. Aortic and mitral valve replacement in idiopathic hypereosinophilic syndrome. Ann Thorac Surg 1988 Nov; 46 (5): 570-1
156. Sakakibara Y, Okamura K, Sakurai J, et al. Successful case of double-valve replacement for aortic steno-regurgitation and mitral stenosis combined with thrombocytopenia and eosinophilia. Kyobu Geka 1982; 35 (7): 558-62
157. Wood AE, Boyle D, O'Hara MD, et al. Mitral annuloplasty in endomyocardial fibrosis: an alternative to valve replacement. Ann Thorac Surg 1982 Oct; 34 (4): 446-51
158. Bell JA, Jenkins BS, Webb-Peploe MM. Clinical, haemodynamic, and angiographic findings in Loffler's eosinophilic endocarditis. Br Heart J 1976 Jun; 38 (6): 541-8
159. Weyman AE, Rankin R, King H. Loeffler's endocarditis presenting as mitral and tricuspid stenosis. Am J Cardiol 1977 Sep; 40 (3): 438-44
160. Cameron J, Radford DJ, Howell J, et al. Hypereosinophilic heart disease. Med J Aust 1985 Oct 28; 143 (9): 408-10
161. Dubost C, Chapelon C, Deloche A, et al. Chirurgie des fibroses endomyocardiques: à propos de 32 cas. Arch Mal Coeur Vaiss 1990 Apr; 83 (4): 481-6
162. Adams HW, Mainz DL. Eosinophilic ascites: a case report and review of the literature. Am J Dig Dis 1977 Jan; 22 (1): 40-2
163. Arvay A, Lengyel M, Meszaros R, et al. Surgical experience with thrombotic and fibrotic forms of non-tropical eosinophilic endomyocardial disease. Thorac Cardiovasc Surg 1985 Oct; 33 (5): 314-6
164. Ikaheimo MJ, Karkola PJ, Takkunen JT. Surgical treatment of Loffler's eosinophilic endocarditis. Br Heart J 1981 Jun; 45 (6): 729-32